Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic Study-Reference-Cited by-同舟云学术

Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic Study

Published:2015-08-11 Issue:8 Volume:12 Page:e1001863
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Christopoulos Katerina A.,Olender Susan,Lopez Andrea M.,Lekas Helen-Maria,Jaiswal Jessica,Mellman Will,Geng Elvin,Koester Kimberly A.

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference25 articles.

1. Office of National AIDS Policy, the White House. National HIV/AIDS Strategy for the United States. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.

2. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection;EM Gardner;Clin Infect Dis,2011

3. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States;HI Hall;JAMA internal medicine,2013

4. Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States;AJ Hughes;Journal of acquired immune deficiency syndromes,2014

5. Individual variability in barriers affecting people's decision to take HAART: a qualitative study identifying barriers to being on HAART;V Alfonso;AIDS Patient Care STDS,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “I Heard of PrEP—I Didn’t Think I Needed it.” Understanding the Formation of HIV Risk Perception Among People Who Inject Drugs;Culture, Medicine, and Psychiatry;2024-07-15

2. Fentanyl smoking in San Francisco: Early signs of a new connoisseurship;Human Organization;2024-07-03

3. Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco;PLOS ONE;2024-05-22

4. The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States;Harm Reduction Journal;2024-03-05

5. Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives;Implementation Science Communications;2023-10-19